Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

1-2 PUNCH: Palliative UNConventional Hypofractionation Trial for Metastatic Bone Disease

NCT05115331 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT05115331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05115331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
1-2 PUNCH: Palliative UNConventional Hypofractionation Trial for Metastatic Bone Disease
Lead sponsor
University of Cincinnati
Phase
Phase 3
Overall status
Active, not recruiting
Start date
November 24, 2021
Completion date
November 24, 2025
Enrollment
168 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic bone tumor